Loading...
Docoh
Log in Free sign up

Milestone Scientific (MLSS)

Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone's proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections.

Company profile

Ticker
MLSS
Exchange
NYSE
Website
www.milestonescientific.com
CEO
Leonard A. Osser
Employees
Incorporated
Delaware
Location
New Jersey
Fiscal year end
Dec 31
Sector
Manufacturing > Surgical and Medical Instrument Manufacturing
Industry (SIC)
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Avanos Medical • Edwards Lifesciences • Invacare • MSA Safety • Align Technology • Wright Medical ...
Former names
MILESTONE SCIENTIFIC INC/NJ, U S OPPORTUNITY SEARCH INC
SEC CIK
0000855683
Corporate docs
Subsidiaries
Wand Dental , Inc. • Milestone Medical Inc. ...
IRS number
133545623

MLSS stock data

News

From Benzinga Pro
Milestone Scientific Expands Medical Indications For CompuFlo Epidural Instrument And Commences Disposable Sales To A Veterinary And Academic Institution
27 May 22
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that it has commenced sales of
Milestone Scientific: Q1 Earnings Insights
17 May 22
Milestone Scientific (AMEX:MLSS) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Milestone Scientific reported in-line EPS of $-0.03 versus an estimate of $-0.03.
Milestone Scientific Q1 EPS $(0.03), Inline, Sales $2.70M Beat $2.50M Estimate
17 May 22
Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 200 percent decrease over losses of $(0.01) per share from the same period last year.
Earnings Scheduled For May 17, 2022
17 May 22
A Preview Of Milestone Scientific's Earnings
16 May 22

Press releases

From Benzinga Pro
Milestone Scientific Announces Distribution Agreement with Clinical Technology, Inc. for the CompuFlo® Epidural System
4 Aug 22
ROSELAND, N.J., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that
Milestone Scientific Commences Sales of its CompuFlo® Epidural System to the University of Scranton for Incorporation in their Student Registered Nurse Anesthesia Curriculum
2 Aug 22
ROSELAND, N.J., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables to a Leading Medical Center in Southern California
7 Jul 22
ROSELAND, N.J., July 07, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that,
American Medical Association Issues Technology-Specific CPT® Code for Milestone Scientific's CompuFlo Epidural System
6 Jul 22
Milestone Scientific Expands Medical Indications for the CompuFlo® Epidural Instrument and Commences Disposable Sales to a Leading Veterinary and Academic Institution
27 May 22

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

15 May 22
12 Aug 22
31 Dec 22

Financial summary

Financial statements Chart MLSS financial data
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 13.25M 13.25M 13.25M 13.25M 13.25M 13.25M
Cash burn (monthly) 503.19K 307.99K 638.16K 692.38K 502.5K 379.77K
Cash used (since last report) 2.22M 1.36M 2.81M 3.05M 2.21M 1.67M
Cash remaining 11.04M 11.9M 10.44M 10.21M 11.04M 11.58M
Runway (months of cash) 21.9 38.6 16.4 14.7 22.0 30.5

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Recent insider trades

MLSS insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
16 Jun 22 Goldman Neal I Common Stock, Par Value $0.001 Buy Acquire P No No 0.75 9,720 7.29K 1,195,934
15 Jun 22 Goldman Neal I Common Stock, Par Value $0.001 Buy Acquire P No No 0.8 5,270 4.22K 1,186,214
13 Jun 22 Giandomenico Trombetta Common Stock, Par Value $0.001 Grant Acquire A No No 0.82 30,488 25K 10,127,204
13 Jun 22 Schiller Leonard M Common Stock, Par Value $0.001 Grant Acquire A No No 0.82 32,012 26.25K 338,412
13 Jun 22 Leslie Bernhard Common Stock, Par Value $0.001 Grant Acquire A No No 0.82 39,634 32.5K 53,992
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

MLSS institutional ownership history Ownership history
7.0% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 38 37 +2.7%
Opened positions 4 6 -33.3%
Closed positions 3 4 -25.0%
Increased positions 4 10 -60.0%
Reduced positions 16 9 +77.8%
13F shares Current Prev Q Change
Total value 7.77M 23.14M -66.4%
Total shares 4.8M 5.24M -8.4%
Total puts 59.7K 34.8K +71.6%
Total calls 21.5K 16.1K +33.5%
Total put/call ratio 2.8 2.2 +28.5%
Largest owners Shares Value Change
Vanguard 2.14M $3.26M -0.4%
Bridgeway Capital Management 526.7K $801K -18.1%
Millennium Management 498.11K $757K -0.4%
Geode Capital Management 353.25K $536K -0.0%
swisspartners 251.83K $383K 0.0%
BLK Blackrock 203.65K $310K -3.3%
STT State Street 96.48K $147K +10.0%
NTRS Northern Trust 85.92K $131K -7.4%
MS Morgan Stanley 78.73K $119K -63.2%
Sequoia Financial Advisors 56.52K $86K NEW
Largest transactions Shares Bought/sold Change
MS Morgan Stanley 78.73K -135.41K -63.2%
Renaissance Technologies 23.08K -132.62K -85.2%
Bridgeway Capital Management 526.7K -116.1K -18.1%
Sequoia Financial Advisors 56.52K +56.52K NEW
Susquehanna International 19.14K -49K -71.9%
Schonfeld Strategic Advisors 33.9K +33.9K NEW
Citadel Advisors 12.95K -29.3K -69.4%
Charles Schwab Investment Management 0 -24.92K EXIT
BAC Bank Of America 282 -23.88K -98.8%
Jane Street 23.07K +23.07K NEW
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Bad
New words: accident, acknowledgement, acquiree, adherence, administer, administering, anxiety, assert, assuring, aware, begun, biomedical, block, branch, breach, broad, Buy, CAPA, carefully, CathCheckTM, Chinese, civil, commodity, confidence, confidential, conflict, conveyance, core, correct, corrective, costly, criminal, data, dba, defense, deferral, demo, desiring, diagnostic, difficulty, discrepancy, disposition, efficacy, efficient, emerging, enhanced, essential, event, freight, frequency, halt, halted, hazard, HC, HHE, highest, HIPAA, id, implement, implementation, importantly, inappropriate, incorrectly, independent, indirect, innovative, inspection, investigation, juncture, key, Kit, launching, leader, legacy, legal, lidong, longer, lot, Mach, maintain, matter, Michelle, mid, Middle, monetary, needle, nerve, oil, Omicron, opted, packaged, pain, painlessly, patient, pioneering, pregnant, privacy, procedural, proven, recovery, rectify, redefining, refusal, remediating, reorganization, retrospectively, RMB, root, routinely, RSA, Russia, satisfaction, Science, settle, sharp, solution, Southeast, spare, spite, stake, strain, stream, stricter, subsidiary, substantive, successfully, suffer, telecommunication, territory, terrorism, therapeutic, tip, traditional, trial, Ukraine, unable, unauthorized, unconstrained, unique, unissued, unpredictable, unvested, upgraded, user, view, violation, virtually, voluntary, vulnerable, war, warehousing, warning, western, wheat, widely, withdrawal, women, worth, Zhang
Removed: abroad, advanced, advantage, Aid, amendment, analyzing, annum, arising, articular, balloon, Bank, Black, borrow, borrower, borrowing, broader, case, certainty, charged, classification, close, collateralized, combined, commencement, commencing, communicated, conform, currency, damaged, debt, delivered, depreciation, determinable, discretion, dissolved, division, documentation, Domenico, economically, eligible, entitled, environment, equivalent, extend, feet, finalized, Fixture, FOB, foreign, forgivable, forgiven, Furniture, generating, Gian, guarantee, implicit, improvement, incremental, inform, Innovest, intra, introductory, liquidity, loan, margin, merger, methodology, mortgage, noncash, notably, occurred, offering, operate, originally, originating, Paycheck, payroll, PPP, Premier, prepaid, prepayment, presentation, priced, processed, Protection, qualifying, readily, Relief, rely, remaining, rentable, replace, repurchase, reserved, residual, Savoy, sector, shipping, Simplifying, standalone, summarized, supplied, suspense, title, treatment, typically, utilize
From filing 10-Q 2022 Q1
Financial reports
View all
10-Q
2022 Q1
Quarterly report
15 May 22
10-K
2021 FY
Annual report
31 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
13 Aug 21
10-Q
2021 Q1
Quarterly report
14 May 21
10-K
2020 FY
Annual report
31 Mar 21
10-Q
2020 Q3
Quarterly report
15 Nov 20
10-Q
2020 Q2
Quarterly report
14 Aug 20
10-Q
2020 Q1
Quarterly report
14 May 20
10-K/A
2019 FY
Annual report (amended)
2 Apr 20
Current reports
View all
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 22
8-K
Departure of Directors or Certain Officers
3 May 22
8-K
Regulation FD Disclosure
20 Jan 22
8-K
Other Events
10 Dec 21
8-K
Departure of Directors or Certain Officers
2 Jul 21
8-K
Submission of Matters to a Vote of Security Holders
17 Jun 21
8-K
Departure of Directors or Certain Officers
7 Apr 21
8-K
Departure of Directors or Certain Officers
24 Mar 21
8-K
Entry into a Material Definitive Agreement
3 Mar 21
8-K
Submission of Matters to a Vote of Security Holders
11 Dec 20
Registration and prospectus
View all
S-8
Registration of securities for employees
14 Jul 21
S-8
Registration of securities for employees
14 Jan 21
424B5
Prospectus supplement for primary offering
26 Jun 20
424B5
Prospectus supplement for primary offering
25 Jun 20
424B5
Prospectus supplement for primary offering
9 Apr 20
424B5
Prospectus supplement for primary offering
8 Apr 20
424B2
Prospectus for primary offering
20 May 19
S-3
Shelf registration
2 May 19
424B5
Prospectus supplement for primary offering
1 Feb 19
424B5
Prospectus supplement for primary offering
31 Jan 19
Proxies
View all
DEF 14A
Definitive proxy
29 Apr 22
DEF 14A
Definitive proxy
30 Apr 21
PRE 14A
Preliminary proxy
9 Apr 21
DEF 14A
Definitive proxy
26 Oct 20
PRE 14A
Preliminary proxy
9 Oct 20
DEF 14A
Definitive proxy
5 Nov 19
PRE 14A
Preliminary proxy
4 Oct 19
DEF 14A
Definitive proxy
29 Apr 18
DEFA14A
Additional proxy soliciting materials
29 Apr 18
DEF 14A
Definitive proxy
11 Apr 17
Other
View all
UPLOAD
Letter from SEC
15 Jun 20
CORRESP
Correspondence with SEC
9 Jun 20
UPLOAD
Letter from SEC
1 Jun 20
EFFECT
Notice of effectiveness
17 May 19
CORRESP
Correspondence with SEC
12 May 19
UPLOAD
Letter from SEC
8 May 19
EFFECT
Notice of effectiveness
3 May 16
CORRESP
Correspondence with SEC
1 May 16
CERTNYS
Certification of approval for NYSE listing
27 May 15
UPLOAD
Letter from SEC
20 Jan 11
Ownership
View all
4
MILESTONE SCIENTIFIC / NEAL I GOLDMAN ownership change
17 Jun 22
4
MILESTONE SCIENTIFIC / NEAL I GOLDMAN ownership change
15 Jun 22
4
MILESTONE SCIENTIFIC / LEONARD OSSER ownership change
15 Jun 22
4
MILESTONE SCIENTIFIC / BENEDETTA I CASAMENTO ownership change
15 Jun 22
4
MILESTONE SCIENTIFIC / NEAL I GOLDMAN ownership change
15 Jun 22
4
MILESTONE SCIENTIFIC / Michael McGeehan ownership change
15 Jun 22
4
MILESTONE SCIENTIFIC / Leslie Bernhard ownership change
15 Jun 22
4
MILESTONE SCIENTIFIC / LEONARD M SCHILLER ownership change
15 Jun 22
4
MILESTONE SCIENTIFIC / Giandomenico Trombetta ownership change
15 Jun 22
4
MILESTONE SCIENTIFIC / BENEDETTA I CASAMENTO ownership change
9 Jun 22

Patents

View all
Utility
Device and Method for Needle/Catheter Location Utilizing Correlation Analysis
28 Oct 21
An apparatus and method to enable clinicians to verify needle or catheter location within an anatomic site by relying upon combined sensing of two signals, such as a pressure signal and a heart rate pulse signal, in which the detection of a correlation between both signals is identified to confirm location of the needle or catheter.
Utility
Device and method for identification of a target region
19 Oct 21
A method and apparatus are provided for use in locating a target region which is situated in the body of a subject, for example for the delivery of drugs.
Utility
Method and Apparatus for Performing a Peripheral Nerve Block
23 Sep 21
A system for infusing medication into a mammalian subject is provided.
Utility
Device and Method for Identification of a Target Region
10 Jun 21
A method and apparatus are provided for use in locating a target region which is situated in the body of a subject, for example for the delivery of drugs.
Utility
Device and method for identification of a target region
30 Mar 21
A method and apparatus are provided for use in locating a target region which is situated in the body of a subject, for example for the delivery of drugs.

Transcripts

View all
2022 Q1
Earnings call transcript
17 May 22
2021 Q4
Earnings call transcript
1 Apr 22
2021 Q3
Earnings call transcript
15 Nov 21
2021 Q2
Earnings call transcript
16 Aug 21
2021 Q1
Earnings call transcript
17 May 21
2020 Q4
Earnings call transcript
2 Apr 21
2020 Q3
Earnings call transcript
17 Nov 20
2020 Q2
Earnings call transcript
17 Aug 20
2020 Q1
Earnings call transcript
18 May 20
2019 Q3
Earnings call transcript
15 Nov 19

Reddit threads

View all